| http://www.w3.org/ns/prov#value | - o the invention are very particularly indicated in the treatment of eczemas, eczematous or psoriatic erythrodermas, pruriginous lesions, chronic lupus erythematosus, psoriasis and parapsoriasis en plaque.These treatments generally require an application as described above 2 to 3 times per week.Several examples of compositions according to the invention will now be given by way of illustration and
|
